June 2015
In this Supplement
Complete Coverage for Complex In-Stent Restenosis
Data, comparative analysis, and consensus on the role of the GORE® VIABAHN® Endoprosthesis.
COMPLETE COVERAGE FOR COMPLEX IN-STENT RESTENOSIS
Data-Driven Treatment Approach to In-Stent Restenosis
By George L. Adams, MD, MHS, FACC, FSCAI; Robert M. Bersin, MD, FACC, FSCAI; Jon C. George, MD, FACC, FSCAI; Vinayak Subramanian, BS; Peter A. Soukas, MD, FACC, FSVM, FSCAI, FACP, RPVI
CASE REPORT
The GORE® VIABAHN® Endoprosthesis for In-Stent Restenosis in the Superficial Femoral Artery
By Robert L. Minor, Jr, MD, and Jeffrey R. Cook, MD
CASE REPORT
The GORE® VIABAHN® Endoprosthesis for Recurrent In-Stent Restenosis
By Peter A. Soukas, MD, FACC, FSVM, FSCAI, FACP, RPVI
CASE REPORT
Treating ISR With the GORE® VIABAHN® Endoprosthesis After Bilateral SFA CTO Interventions
By Robert M. Bersin, MD, FACC, FSCAI
Innovation Fueling Evolution: Two Decades of the GORE® VIABAHN® Endoprosthesis
Through the incorporation of technological advances, the contemporary GORE VIABAHN Device has evolved to offer robust treatment options to a diverse and growing population of patients with peripheral artery disease.
By M. Casey Becker, MD, FACC, FSCAI, FSVM
Optimal Technique for Use of the GORE® VIABAHN® Endoprosthesis
Best practices and treatment considerations for using stent-grafts.